Please login to the form below

Zontivity

This page shows the latest Zontivity news and features for those working in and with pharma, biotech and healthcare.

FDA reviewer backs approval of TMC's cangrelor

Additional competition in the category will also come from Merck &Co's first-in-class protease-activated receptor-1 (PAR-1) antagonist Zontivity (vorapaxar) - which was cleared for marketing in the

Latest news

R&D productivity takes off

Other first-in-class agents include: Merck &Co's PAR-1 antagonist Zontivity (vorapaxar), a novel antiplatelet agent; AstraZeneca's PARP inhibitor Lynparza (olaparib) for cancer; Otsuka's Deltyba (delamanid), a
Orphan drugs in latest CHMP recommendations

s Zontivity (vorapaxar), which was recommended for the reduction of atherothrombotic events.
Merck's first-in-class Zontivity cleared in US

Merck's first-in-class Zontivity cleared in US. FDA approves the protease-activated receptor-1 antagonist to reduce heart attack risk. ... Merck plans to launch Zontivity in the US in the coming weeks, while the PAR-1 antagonist is also under regulatory
FDA panel backs Merck's vorapaxar

Vorapaxar - which Merck plans to sell under the brand name Zontivity - is an orally-active protease-activated receptor 1 (PAR-1) inhibitor that targets thrombin-induced platelet activation. ... If the FDA follows the panel's advice - which it generally

More from news
Approximately 1 fully matching, plus 4 partially matching documents found.

Latest Intelligence

Deal Watch September 2016

Merck &Co has sold the US and Canadian rights for its Zontivity, or vorapaxar, to Aralez Pharmaceuticals in an asset purchase agreement worth $25m. ... Zontivity is a protease-activated receptor-1 antagonist indicated for use in combination with daily

More from intelligence
Approximately 0 fully matching, plus 1 partially matching documents found.

Featured jobs

Account Manager, MedicalCommunications/ Healthcare PR: benefits

Medical Writer - Creative and Scientific Projects: DOE

Scientific Director – Medical Communications - New York or Remot...: $100000 - $150000

Senior Account Manager / Account Director - Medical Education – ...: Salary TBC

Account Director or Senior Account Director: Salary TBC

Senior Medical Writer, Principal Medical Writer, Scientific Dire...: £40000 - £75000 Bonus Benefits

Graduate Scientific Editor: DOE

Account Director, Medical Communications & Events: £50 - 65, 000 according to skills and experience benefits

Head of Market Access - International - Based Cambridge: Excellent Basic, Bonus and Flex Benefits

Account Manager: Negotiable

Healthcare PR Senior Account Manager: Salary TBC

Senior Strategist/ Planner, Healthcare Marketing, London: Excellent package

Principal Medical Writer / Editorial Director – Medical Communic...: £60, 000 - £80, 000

Sudler London - Account Director: Competitive

Science Writer, Healthcare Advertising Agency: £40, 000 - 45, 000 DOE benefits,

Account Manager, Healthcare Advertising: £30 - 38, 000 (or -)

Account Manager- 4 days per week or full-time: Salary TBC

Technical Manager – Developer and Commercial Excellence, Healthc...: Excellent package

Senior Training Manager - Surrey: Competitive Salary &Bonus

Senior Writer, Healthcare Advertising, London: Excellent package

Sudler London - Senior Medical Writer: Competitive

Healthcare PR Director: £100, 000 – £120, 000 benefits

Account Director - Award Winning Healthcare Advertising Agency -...: £50000 - £68000

Deputy Managing Director – Healthcare PR – Global Agency: Negotiable

Market Access Consultant - Greater Manchester: Negotiable

Subscribe to our email news alerts

PMHub

Add my company

Research Partnership

We are one of the largest independent healthcare market research and consulting agencies in the world. Trusted partner to the...

Latest intelligence

PM Society Digital Awards – the power of together: Our chief executive, Emma Statham, writes about the value of awards and the power of together....
Seduce anyone in four simple steps: You know the health of the global economy is dependent on our ability to seduce one another – don’t you? And you know that we need to be able to...
What Would Jeremy Do? : Assessing the impact of a Corbyn-led Labour government: GK Strategy are delighted to announce the launch our latest briefing paper entitled ‘What Would Jeremy Do? Assessing the impact of a Corbyn-led Labour government’....